Top

Published in:

Open Access 01-12-2005 | Review

Global health priorities – priorities of the wealthy?

Author: Eeva Ollila

Published in: Globalization and Health | Issue 1/2005

Abstract

Health has gained importance on the global agenda. It has become recognized in forums where it was once not addressed. In this article three issues are considered: global health policy actors, global health priorities and the means of addressing the identified health priorities. I argue that the arenas for global health policy-making have shifted from the public spheres towards arenas that include the transnational for-profit sector. Global health policy has become increasingly fragmented and verticalized. Infectious diseases have gained ground as global health priorities, while non-communicable diseases and the broader issues of health systems development have been neglected. Approaches to tackling the health problems are increasingly influenced by trade and industrial interests with the emphasis on technological solutions.

Koivusalo M, Ollila E: Making a healthy world. Agencies, actors & policies in international health. 1997, London: Zed Books

Ollila E: Restructuring global health policy making: the role of global public-private partnerships. Commercialization of Health Care: Global and Local Dynamics and Policy Responses. Edited by: UNRISD by Mcintosh M, Koivusalo M. Palgrave

Koivusalo M: The impact on WTO trade agreements on health and development policies. Global Social Governance. Themes and prospects. Edited by: Deacon B, Ollila E, Koivusalo M, Stubbs P. 2003, 77-129. Helsinki: Ministry of Foreign Affairs of Finland, http://www.gaspp.org/publications/global-s.pdf

Lethbridge J: International Finance Corporate (IFC) health care policy briefing. Global Social Policy. 2002, 2: 349-353.

Buse K, Walt G: Global public-private partnerships for health: part I – a new development in health. Bull World Health Organ. 2002, 78: 549-61.

Ollila E: Health-related public-private partnerships and the United Nations. Global Social Governance. Themes and prospects. Edited by: Deacon B, Ollila E, Koivusalo M, Stubbs P. 2003, 36-76. Helsinki: Ministry of Foreign Affairs of Finland, http://www.gaspp.org/publications/global-s.pdf

Richter J: Public-private partnerships and international health policy-making. How can public interests be safeguarded?. 2004, Helsinki: Ministry for Foreign Affairs of Finland, http://global.finland.fi/julkaisut/pdf/public_private2004.pdf

Zammit A: Development at risk. Rethinking UN-business partnerships. 2003, South Centre and UNRISD, Geneva

Utting P: "UN-Business Partnerships: Whose Agenda Counts?". conference: Partnerships for Development or Privatization of the Multilateral System, North-South Coalition: 8 December 2000; Oslo, Norway. 2000, http://www.unrisd.org

10.

Tesner S, Kell WG: The United Nations and business. A partnership recovered. 2000, New York: St. Martin's Press

11.

Walt G: Health Policy. An Introduction to process and power. 1994, Johannesburg, London and NewJersey: Witwatersrand University Press and Zed Books

12.

OECD: Recent trends in official development assistance to health. 2000, http://www.oecd.org/dataoecd/22/31/25503059.pdf

13.

Kickbusch I: Influence and opportunity: Reflections on the U.S. role in global public health. Health Affairs. 2002, 21: 131-41.CrossRefPubMed

14.

Barry T: US isn't "stingy", it's strategic. International Relations Center, Silver City, NM. January 7, 2005, http://www.irc-online.org/content/commentary/2005/0501aid.php

15.

Kagan R: Power and weakness. Policy Review. 2002, 113: http://www.policyreview.org/JUN02/

16.

Koivusalo M, Ollila E: Digest. Global Social Policy. 2001, 1: 125-144.CrossRef

17.

Kickbusch I: Global health governance: some theoretical considerations on the new political space. Health impacts of globalization. Towards Global governance. Edited by: Lee K. 2003, 192-203. London: Palgrave Macmillan

18.

United Nations: Road map towards the implementation of the United Nations Millennium Declaration. Report of the Secretary-General A/56/326. 6 September 2001

19.

United Nations General Assembly: United Nations Millennium Declaration. Resolution A/RES/55/2. 18 September 2000

20.

Horton R: WHO's mandate: a damaging reinterpretation is taking place. Lancet. 2002, 360: 960-1.CrossRefPubMed

21.

UNIFEM: Pathway to gender equality: CEDAW, Beijing and the MDGs. http://www.unifem.org/index.php?f_page_pid=216

22.

The World Health Organization: The World Report. Better knowledge for health. Strengthening health systems. Geneva. 2004

23.

Millennium Project: Investing in development. A practical plan to achieve the millennium development goals. New York. 2005

24.

Commission on Macroeconomics and Health: Macroeconomics and Health: investing in health for economic development. 2001, Geneva: World Health Organization

25.

Yach D, Hawkes C, Gould CL, Hofman KJ: The global burden of chronic diseases. JAMA. 2004, 21: 2616-22. 10.1001/jama.291.21.2616.CrossRef

26.

USAID: Total population, health and nutrition funding, FY 2002. http://www.usaid.gov/our_work/global_health/home/Funding/index.html

27.

World Health Organization:: World Health Report 2002. Reducing risks, promoting healthy life. Geneva. 2002

28.

Bill and Melinda Gates Foundation: Global Health Programme fact sheet. http://www.gatesfoundation.org/GlobalHealth/RelatedInfo/GlobalHealthFactSheet-021201.htm

29.

Varmus H, Klausner R, Zerhouni E, Acharya T, Daar AS, Singer PA: Public Health. Grand Challenges in global health. Science. 2003, 302: 398-9.PubMedCentralCrossRefPubMed

30.

Grimes S: From population control to "reproductive rights": ideological influences in population policy. Third World Q. 1998, 19: 375-93.CrossRefPubMed

31.

National Security Council: National Security Memorandum 200. Washington, D.C. 1974

32.

U.S. Department of State and U.S. Agency for International Develop-ment: Security, democracy, prosperity. Strategic plan fiscal years 2004–2009. 2003, http://www.state.gov/m/rm/rls/dosstrat/2004/

33.

Hardon A: Immunization for all? A critical look at the first GAVI partners meeting. HAI-Lights. 2000, 6 (1): 2-9.

34.

Yamey G: WHO in 2002. Faltering steps towards partnerships. BMJ. 2002, 325: 1236-1240.PubMedCentralCrossRefPubMed

35.

Poore P: The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM). Health Policy Plann. 2004, 19: 52-53. 10.1093/heapol/czh006.CrossRef

36.

Brugha R, Walt G: A global health fund: a leap of faith. BMJ. 2001, 323: 152-4.PubMedCentralCrossRefPubMed

37.

GAVI Financing task force: GAVI Financing task force. GAVI BOard meeting. 7 July, 2004, http://www.vaccinealliance.org/site_repository/resources/13th_brd_Bridge_Funding_Board_presentation_DRAFT_july_5th.ppt

38.

Starling M, Brugha R, Walt G: New products into old systems. The global alliance for vaccines and immunizations (GAVI) from a country perspective. Save the children London. 2002

39.

United Nations: Co-operation between the United Nations and all relevant partners, in particular the private sector. Report of the Secretary-General to the General Assembly. Item 47 of the provisional agenda: Towards global partnerships. New York, United Nations. 2003

40.

Chetley A: A healthy business. World health and pharmaceutical industry. 1990, London and New Jersey: Zed Books

41.

Hardon A: Consumers versus producers: power play behind the scenes. Drugs policy in developing countries. Edited by: Kanji N, Hardon A, Harnmeijer JW, Mamdani M, Walt G. 1992, 48-64. London and New Jersey: Zed Books

42.

Kopp C: WHO industry partnership on the hot seat. BMJ. 2000, 321: 958-PubMed

43.

Hayes L: Industry's growing influence at the WHO. Global Policy Forum, UN reform Archives. 15 December 2001, http://www.globalpolicy.org/reform/2001/0223who.htm

44.

Muraskin W: The last years of the CVI and the birth of the GAVI. Public-private partnerships for public health. Edited by: Reich MR. 2002, 115-68. Cambridge, Massachusetts; Harvard Center for Population and Development Studies

45.

Phillips M: 'Infectious-disease fund stalls amid U.S. rules for disbursal', . Wall Street Journal. August 5, 2002

46.

Stansfield SK, Harper M, Lamb G, Lob-Levyt J: Innovative financing of international public goods for health. CMH working paper series WG2:22. Commission on Macroeconomics and Health. 2002, http://www.cmhealth.org/docs/wg2_paper22.pdf

47.

IMF: Public-private partnerships. 2004, http://www.servicesforall.org/html/Privatization/IMF_Public_Private_Partnerships.pdf

Title: Global health priorities – priorities of the wealthy?
Author: Eeva Ollila
Publication date: 01-12-2005
Publisher: BioMed Central
Published in: Globalization and Health / Issue 1/2005
Electronic ISSN: 1744-8603
DOI: https://doi.org/10.1186/1744-8603-1-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Global health priorities – priorities of the wealthy?

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2005

The global diet: trade and novel infections

To quell obesity, who should regulate food marketing to children?

TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana

Globalisation, health and foreign policy: emerging linkages and interests

Medicines and vaccines for the world's poorest: Is there any prospect for public-private cooperation?

Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy